Tesamorelin Price Comparison — Compare 35 Vendors

View full research →
Visceral fat / lipolysis researchSafety Rating 8/10
Compared to FDA-approved pricing

Save ~99% vs Manufacturer direct

Egrifta SV / Egrifta WRManufacturer direct
$3,000/mo
Research-grade TesamorelinPeptidePrices · cheapest verified
$39/mo

Research-grade Tesamorelin is for laboratory and research use only, not approved for human consumption. Always consult a licensed physician before working with any compound. FDA-approved 2010 for HIV-associated lipodystrophy. Specialty pricing means retail and cash-pay are essentially identical. Off-label use for VAT reduction is what drives research-vendor demand.

See all Tesamorelin vendors →

Price Comparison

Compare vendors · per 10mg

35 vendors competing

VendorPrice$ / mgUpdated
Alpha Peptides8/10$38.90$43.22−10% · code PEPTIDEPRICES10$3.89Jun 12, 2026Buy →
Hydro Research9/10$44.00$55.00−20% · code PEPTIDEP20$4.40Jun 5, 2026Buy →
Puratek Peptides9.5/10$94.45$104.95−10% · code PEPTIDEPRICES$4.72May 19, 2026Buy →
Amino Club10/10$155.38$194.22−20% · code PEPTIDEPRICES$5.18May 14, 2026Buy →
Peptyx Labs8.5/10$52.00$65.00−20% · code PEPTIDEPRICES25$5.20May 26, 2026Buy →
Glacier Aminos9.5/10$106.19$117.99−10% · code peptidep$5.31Jun 23, 2026Buy →

Research details

Tesamorelin — research data

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range1.4 mg (Egrifta SV) or 1.28 mg (Egrifta WR) SC dailysource ↗
AdministrationSubcutaneous injection (abdomen)
Half-life~26–38 minutes
Safety8/10 · FDA-approved (Egrifta)
NCAA D1Banned

Overview

About Tesamorelin

Mechanism of action

Stabilized GHRH analogue; stimulates pulsatile GH release; reduces visceral adipose tissue (VAT) via IGF-1 mediated lipolysis. FDA-approved for HIV-associated lipodystrophy.

Safety profile

Water retention, joint pain, insulin resistance, peripheral edema, injection site reactions, glucose elevation. · Approved for HIV lipodystrophy; injection site reactions; fluid retention; well-characterized

Storage

Stability & handling

❄️Lyophilized (powder)2–8°Cas labeled
💉Reconstituted2–8°Cwithin 28 days
📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Safety & Interactions

Contraindications & Drug Interactions

Research use only — not medical advice. Consult a licensed physician before using any peptide. Sources are cited where available.

⚠ CriticalContraindication

Active malignancy.

⚠ CriticalContraindication

Pituitary disease (hypopituitarism, pituitary tumor, etc.).

⚠ CriticalContraindication

Pregnancy — embryofetal toxicity.

Sources: FDA

Related pages

More on Tesamorelin

Stack & Compare

Frequently Researched Together

Learn More

Tesamorelin Guide

The FDA-approved GHRH analog used in body composition research.

Read full guide · 8 min read →

Research

Studies & key findings

  • FDA-approved (Egrifta) for HIV-associated lipodystrophy — reduces visceral adipose tissue by 15–18% in pooled Phase 3 analyses, with Study 1 showing 15.2% VAT reduction vs a 5% increase in placebo at 26 weeks.
  • Reduces liver fat and improves hepatic transcriptomics in HIV-associated NAFLD, suggesting benefit beyond cosmetic fat redistribution.

6 peer-reviewed sources cited — clinical, preclinical, and regulatory.

Read full research →
Failed to fetch